- Report
- January 2022
- 200 Pages
Global
From €7251EUR$7,500USD£6,228GBP
Gestational diabetes is a type of diabetes that occurs during pregnancy and affects the mother's ability to produce and use insulin. Endocrine and Metabolic Disorders Drugs are used to treat gestational diabetes and other endocrine and metabolic disorders. These drugs are used to regulate blood sugar levels, reduce insulin resistance, and reduce the risk of complications associated with gestational diabetes. Commonly prescribed drugs include insulin, metformin, and glyburide. Insulin is used to replace the insulin that the body is unable to produce, while metformin and glyburide are used to reduce insulin resistance.
The Gestational Diabetes Drug market is a rapidly growing market, driven by the increasing prevalence of gestational diabetes and the rising demand for effective treatments. The market is expected to continue to grow in the coming years, as more women are diagnosed with gestational diabetes and the need for effective treatments increases.
Some companies in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more